353 related articles for article (PubMed ID: 27645111)
21. High-dose statin therapy: benefits and safety in aggressive lipid lowering.
Toth PP; Davidson MH
J Fam Pract; 2008 May; 57(5 Suppl High-Dose):S29-36. PubMed ID: 18662521
[No Abstract] [Full Text] [Related]
22. Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016).
Mancini GB; Baker S; Bergeron J; Fitchett D; Frohlich J; Genest J; Gupta M; Hegele RA; Ng D; Pearson GJ; Pope J; Tashakkor AY
Can J Cardiol; 2016 Jul; 32(7 Suppl):S35-65. PubMed ID: 27342697
[TBL] [Abstract][Full Text] [Related]
23. 2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance.
Chien SC; Chen PS; Huang YH; Tang SC; Li YH; Yeh HI
J Formos Med Assoc; 2019 Oct; 118(10):1385-1392. PubMed ID: 30584005
[TBL] [Abstract][Full Text] [Related]
24. [Statin intolerance].
Graversen CB; Larsen ML; Schmidt EB
Ugeskr Laeger; 2015 Aug; 177(36):. PubMed ID: 26324293
[TBL] [Abstract][Full Text] [Related]
25. Practical aspects in the management of statin-associated muscle symptoms (SAMS).
Laufs U; Filipiak KJ; Gouni-Berthold I; Catapano AL;
Atheroscler Suppl; 2017 Apr; 26():45-55. PubMed ID: 28434484
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update.
Mancini GB; Tashakkor AY; Baker S; Bergeron J; Fitchett D; Frohlich J; Genest J; Gupta M; Hegele RA; Ng DS; Pearson GJ; Pope J
Can J Cardiol; 2013 Dec; 29(12):1553-68. PubMed ID: 24267801
[TBL] [Abstract][Full Text] [Related]
27. Cardiology patient page. Statin intolerance.
Fitchett DH; Hegele RA; Verma S
Circulation; 2015 Mar; 131(13):e389-91. PubMed ID: 25825402
[No Abstract] [Full Text] [Related]
28. Statin myopathy: over-rated and under-treated?
Maghsoodi N; Wierzbicki AS
Curr Opin Cardiol; 2016 Jul; 31(4):417-25. PubMed ID: 27258372
[TBL] [Abstract][Full Text] [Related]
29. Managing statin-induced muscle toxicity in a lipid clinic.
Blaier O; Lishner M; Elis A
J Clin Pharm Ther; 2011 Jun; 36(3):336-41. PubMed ID: 21414023
[TBL] [Abstract][Full Text] [Related]
30. Statin intolerance.
Ahmad Z
Am J Cardiol; 2014 May; 113(10):1765-71. PubMed ID: 24792743
[TBL] [Abstract][Full Text] [Related]
31. Current overview of statin-induced myopathy.
Rosenson RS
Am J Med; 2004 Mar; 116(6):408-16. PubMed ID: 15006590
[TBL] [Abstract][Full Text] [Related]
32. Management of Statin Intolerance in 2018: Still More Questions Than Answers.
Toth PP; Patti AM; Giglio RV; Nikolic D; Castellino G; Rizzo M; Banach M
Am J Cardiovasc Drugs; 2018 Jun; 18(3):157-173. PubMed ID: 29318532
[TBL] [Abstract][Full Text] [Related]
33. Statin intolerance.
Laufs U; Scharnagl H; März W
Curr Opin Lipidol; 2015 Dec; 26(6):492-501. PubMed ID: 26780003
[TBL] [Abstract][Full Text] [Related]
34. Clinical and laboratory phenotype of patients experiencing statin intolerance attributable to myalgia.
Harris LJ; Thapa R; Brown M; Pabbathi S; Childress RD; Heimberg M; Braden R; Elam MB
J Clin Lipidol; 2011; 5(4):299-307. PubMed ID: 21784376
[TBL] [Abstract][Full Text] [Related]
35. Resistance and intolerance to statins.
Reiner Z
Nutr Metab Cardiovasc Dis; 2014 Oct; 24(10):1057-66. PubMed ID: 24996502
[TBL] [Abstract][Full Text] [Related]
36. Red yeast rice may be a statin substitute. People who are statin-intolerant due to side effects of muscle pain may benefit from this ancient Asian dietary and medicinal staple.
Duke Med Health News; 2009 Sep; 15(9):1-2. PubMed ID: 19785077
[No Abstract] [Full Text] [Related]
37. Identification and Management of Statin-Associated Symptoms in Clinical Practice: Extension of a Clinician Survey to 12 Further Countries.
Rosenson RS; Gandra SR; McKendrick J; Dent R; Wieffer H; Cheng LI; Catapano AL; Oh P; Kees Hovingh G; Stroes ES
Cardiovasc Drugs Ther; 2017 Apr; 31(2):187-195. PubMed ID: 28466399
[TBL] [Abstract][Full Text] [Related]
38. LDL-C does not cause cardiovascular disease: a comprehensive review of the current literature.
Ravnskov U; de Lorgeril M; Diamond DM; Hama R; Hamazaki T; Hammarskjöld B; Hynes N; Kendrick M; Langsjoen PH; Mascitelli L; McCully KS; Okuyama H; Rosch PJ; Schersten T; Sultan S; Sundberg R
Expert Rev Clin Pharmacol; 2018 Oct; 11(10):959-970. PubMed ID: 30198808
[TBL] [Abstract][Full Text] [Related]
39. Pearls & Oy-sters: Managing Cholesterol in a Patient With Statin Intolerance Due to Anti-HMG-CoA Reductase-Associated Myopathy.
Villa E; Naves R; Bezares K; Cobeña K; Villarroel AC; Guevara C
Neurology; 2022 Nov; 99(20):909-913. PubMed ID: 36100441
[TBL] [Abstract][Full Text] [Related]
40. Safety and tolerability of injectable lipid-lowering drugs: a review of available clinical data.
Cicero AF; Tartagni E; Ertek S
Expert Opin Drug Saf; 2014 Aug; 13(8):1023-30. PubMed ID: 24961142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
